A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil - Concepedia

Concepedia

Publication | Open Access

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

DOI Full Paper Access

33

Citations

10

References

2018

Year

Terence Fullerton, Brendon Binneman, William David, Marielle Delnomdedieu, James W. Kupiec, Peter Lockwood, Jessica Mancuso, Jeffrey Miceli, J. Simon Bell

Alzheimer s Research & Therapy

References

	Year	Citations

Page 1